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The relationship between patient physiology and cancer-specific
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The impact of patient physiology on cancer-specific survival is poorly documented. Patient physiology predicted overall, cancer-
specific (Physiology Score430; HR 8.64 (95% CI 3.00–24.92); P¼0.0005) and recurrence-free survival (Physiology Score 430; HR
7.44 (95% CI 1.99–27.73); P¼0.003) independent of Dukes stage following potentially curative surgery for colorectal cancer. This
independent negative association with survival is a novel observation.
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Several factors have independent prognostic significance to
cancer-specific survival following colorectal cancer (CRC) resec-
tion that may be classified according to tumour stage, clinical,
pathologic, oncogenetic, molecular and immunologic variables
(Chapuis et al, 1985; Hole and McArdle, 2002; McArdle and Hole,
2002). Recently, the systemic inflammatory response in CRC
survival, as determined by C-reactive protein (CRP), has provoked
interest (Shunyakov et al, 2004) and may reflect a tumour’s
malignant potential. Elevated CRP levels have been found to
predict survival, independent of Dukes stage (McMillan et al, 2003;
Canna et al, 2004), although others refute this finding (Chung and
Chang, 2003a,b). The systemic inflammatory response may also
predict first cardiac events (Lloyd-Jones and Levy, 2003) and
diabetes onset (Pradhan et al, 2001, 2003). Obesity and smoking
are associated with the systemic inflammatory response (Ohsawa
et al, 2005; Park et al, 2005). These comorbidities are likely to
affect patient physiology. Whether these factors combine with
oncological factors to impair survival is unclear. Few colorectal
studies incorporate comorbidities in their predictive models of
cancer-specific and overall survival. Canna et al (2004) combined
CRP and Dukes stage to provide a more accurate assessment of
prognosis, with promising results, however, few data exist that
assess patient physiology and cancer outcomes.
For surgical patients, the accurate staging and prediction of
peri-operative complications are fundamental to treatment plan-
ning. Accurate evaluation of physiological derangement requires
comparatively few parameters. The Physiological and Operative
Severity Score for the enumeration of Mortality and Morbidity
(POSSUM) was developed in 1991 (Copeland et al, 1991) from
multivariate discriminant analysis, and uses 12 independent
physiological variables to provide a Physiology Score and a six-
factor Operative Severity Score, for predicting operative mortality.
Further refinements have generated the Colorectal (CR) POSSUM
(Tekkis et al, 2004), where six of the 12 original factors were
independent predictors of operative outcome for colorectal
surgery.
The aim of this study was to examine the relationship between
patient physiology and overall, recurrence-free and cancer-specific
survival after potentially curative resection of CRC.
METHODS
A prospective cohort study was conducted based on consecutive
patients undergoing colon and rectal cancer resection from
January 1996 to January 2001, followed until death or to June
2005 with data recorded prospectively in a computerised database.
Operations were classified as elective, emergency, urgent and
scheduled. Preoperative physiology was assessed using POSSUM
Physiology Score and categorised into four groups: 11–14, 15–20,
21–30 and 430 (Tekkis et al, 2004). Histopathological examina-
tion of all surgical specimens followed a standard protocol. Dukes
(Dukes and Bussey, 1958) and TNM systems were used. Tumour
differentiation was classified as well moderate and poor (Halvorsen
and Seim, 1988). Only potentially curative resections were
considered in this study. Palliative resections were defined as
those with known residual tumour, either distant or local. Cause of
death was recorded prospectively by colorectal nurse specialists,
consultant surgeons and the Clinical Effectiveness Unit of the
hospital and the mortality coding protocol for the study
categorised death as CRC-related or from other causes/non-CRC-
related. If post-mortem examination was performed then this
information was considered.
Statistical analyses
Overall survival analysis evaluated deaths from all causes.
Observations were uncensored (complete) if the patient died of
any cause in the follow-up period. This included postoperative
deaths, deaths from CRC and deaths from events unrelated to CRC.
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sCancer-specific survival analysis evaluated deaths from CRC.
Observations were uncensored (complete) only if the patient died
as a direct result of CRC in the follow-up period. Cancer-specific
survival time was measured from the date of resection to the date
of death owing to CRC, with patients lost to follow-up and those
who died of other causes censored in survival analysis.
Recurrence-free survival related to the identification of recur-
rent CRC based upon clinical, pathological or radiological findings.
Observations were uncensored (complete) if a patient was
identified as having recurrent disease, locally or systemically,
during the follow-up period.
Comparisons of survival time between strata of categorical
variables were made using the Kaplan–Meier method (Kaplan and
Meier, 1958) and log-rank test (Wellek, 1993). In addition, survival
analyses employed the Cox proportional hazards model for
variables assessed for prognosis. Multiple regression for variables
showing a significant association with survival employed the
Cox (1972) method. Statistical significance was set at 0.05 and
confidence intervals (CI) were 95%. SPSS for Windows Version 13.0
was used for statistical analyses.
RESULTS
Five hundred and thirty-eight CRC resections were performed over
the 5 year period to 2001. Four hundred and thirty-two resections
were with curative intent and this study only considers survival in
this group of patients. One patient was unspecified in surgical
intent. Follow-up data were absent in five patients who were
censored in analysis of overall, recurrence-free and cancer-specific
survival. At the end of the study period, 226 (52.3%) were dead and
206 (47.7%) were alive. Sixty-three (14.6%) patients succumbed to
CRC, and the median survival in this group was 22 months (IQR
13–40). One hundred and sixty-three patients (37.7%) died from
other causes. The median follow-up for survivors was 74 months
(IQR 60.5–88.0). Summary data are presented in Table 1.
In the curative group, neo-adjuvant or adjuvant therapies were
given in 96 (22.2%) patients. Sixty-eight received chemotherapy; 11
combined postoperative chemoradiotherapy; four combined pre-
operative chemoradiotherapy; six preoperative radiotherapy; three
postoperative radiotherapy; four received ‘other’ treatments.
Of the comorbidities assessed, 99 patients were smokers
(22.9%), 129 were ex-smokers (29.9%) and 202 non-smokers
(46.8%). Data were unrecorded in two patients. Seventy-eight
patients had COPD/asthma (18.1%), 22 had a previous myocardial
infarction (5.1%) with 111 documented with ischaemic heart
disease (IHD) (25.7%), hypertension was documented in 134
(31.0%), diabetes in 28 (6.5%) and a ‘renal’ history in nine (2.1%).
one hundred and sixty six patients had two or more comorbidities
(38.4%).
Overall survival in relation to patient physiology is shown in
Figure 1, and a significant association with overall survival is
identified (log rank 79.24, df¼3, P¼0.0005). The effect of patient
physiology on 5-year cancer-specific survival and 5-year recur-
rence-free survival are considered in Figures 2 and 3, respectively,
where significant associations are also identified.
Univariate survival analyses for curative resections found Dukes
stage, tumour differentiation, adjuvant therapy use and Physiology
Score to significantly predict cancer-specific (Table 2) and
recurrence-free survival (Table 3). Postoperative complications
were significantly related to recurrence-free survival.
Multivariate analysis found patient physiology (P¼0.0005) and
Dukes stage (P¼0.0005) to be independent predictors of cancer-
specific survival (Table 2) and patient physiology, Dukes stage and
postoperative complications to be significant for recurrence-free
survival (Table 3).
In the group of patients at high risk of developing tumour
recurrence, that is, Dukes C, we noted a significant association
with patient physiology and the likelihood of adjuvant/
neo-adjuvant therapy being administered (w
2¼35.23, df¼3;
P¼0.0005). Of the 155 Dukes C patients, 77 (49.3%) received
adjuvant therapies and 78 (50.7%) received no additional therapy.
When patients were categorised by scores of o30 or 430, patients
Table 1 Characteristics of 432 patients who underwent curative
resection of colorectal cancer
Patients n¼432 %
Median age (IQR) 72 (63–78) —
Gender 221M:211F
Elective 344 79.6
Emergency 23 5.3
Urgent 22 5.1
Scheduled 43 10.0
Physiology Score
11–14 53 12.3
15–20 124 28.8
20–30 220 51.2
430 33 7.7
Tumour differentiation
Well 72 16.7
Intermediate 278 64.4
Poor 66 15.3
Unrecorded 16 3.7
Dukes stage
Dukes A 105 24.3
Dukes B 172 39.8
Dukes C 155 35.9
Dukes D — —
All additional therapies
Yes 96 22.2
No 336 77.8
Disease recurrence
Yes 63 14.6
No 370 85.4
Cause of death
CRC related 63 14.6
Other cause/non-CRC related 163 37.7
CRC¼colorectal cancer; IQR¼interquartile range.
S
u
r
v
i
v
a
l
1.0
0.8
0.6
0.4
0.2
0.0
0 1 02 03 04 05 06 0
Overall survival (months)
Physiology
score
11−14
15 − 20
21 − 30
> 30
Figure 1 Five-year overall survival curve according to patient physiology
after curative resection of 432 colorectal cancers.
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sin the better physiology group were significantly more likely to
receive adjuvant therapy (odds ratio (OR)¼5.36 (95% CI 1.64–
17.59); P¼0.002). When adjuvant/neo-adjuvant therapy is sub-
divided by Physiology Scores we find: 11–14; 20 adjuvant therapy,
two no adjuvant therapy; 15–20; 29 adjuvant therapy, 14 no
adjuvant therapy; 21–30; 27 adjuvant therapy, 52 no adjuvant
therapy; 430; one adjuvant therapy, 10 no adjuvant therapy. The
numbers of recurrences in each group were 11–14: five out of 22:
15–20; 10 out of 43; 21–30: 23 of 79; 430: eight out of 11. In the
group which received adjuvant/neo-adjuvant treatment, patient
physiology was not significantly associated with recurrence
(w
2¼3.26, df¼3; P¼0.353). However, in the group receiving no
adjuvant/neo-adjuvant therapy, a significant association with
recurrence and poorer physiology was identified (w
2¼8.743.26,
df¼3; P¼0.033).
DISCUSSION
In the present study, we examined the influence of patient
physiology on cancer-specific and recurrence-free survival in a
group of consecutive patients assessed after potentially curative
CRC resection from a west of Scotland population. The study has
prospectively pursued a large number of cases with an almost
complete dataset and accurate follow-up in over 98% of patients.
On univariate and multivariate analyses, patient physiology,
as assessed by the POSSUM Physiology Score and Dukes stage
were independent predictors of cancer-specific and recurrence-free
survival. Currently, no evidence is available to make valid
comparisons of cancer outcomes in relation to physiology.
The mechanism by which deranged patient physiology may
influence cancer survival is not clear, and no clear explanations are
provided from this study. We have based the physiology score
categories on previously published data (Tekkis et al, 2004).
However, we note that we have documented a higher proportion of
cases with elevated or poorer physiology scores than the cited
study, for example, 21–30 (51 vs 15%) and 430 (8 vs 3%). These
differences may highlight geographical variations in general health,
and the physiology findings may, therefore, not be applicable to
the UK population on the whole. Issues specifically concerning
deprivation have not been assessed in this study. Moreover, the
difference in proportions cannot be explained by differences in the
proportion of emergency procedures as the 5.1% rate observed is
in keeping with UK national data.
Of interest, we noted that patients with better physiology were
significantly more likely to receive adjuvant therapy (OR 5.36 (95%
CI 1.64–17.59); P¼0.002) for Dukes C lesions. It may be disputed
that if patients with comorbid illness and poor physiology were to
develop a local or distant recurrence, they may be denied further
treatments including chemotherapy, radiotherapy or salvage
surgery, as they may be too unfit. Alternatively, patients with a
good physiology score and tumour recurrence may have a better
prognosis and survival if their recurrence is treated aggressively. If
this were the case then our results would be distorted. However, in
the group of patients who received no adjuvant/neo-adjuvant
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Figure 2 Five-year cancer-specific survival curve according to patient
physiology after curative resection of 432 colorectal cancer patients.
1.0
0.8
0.6
0.4
0.2
0.0
0 1 02 03 04 05 06 0
Recurrence-free survival (months)
S
u
r
v
i
v
a
l
Physiology
score
11−14
15 − 20
21 − 30
> 30
Figure 3 Five-year recurrence-free survival curve according to patient
physiology after curative resection of 432 colorectal cancer patients.
Table 2 Relationship between variables and cancer-specific survival following curative resection for colorectal cancer of 432 patients
Univariate analysis Multivariate analysis
Variable Hazard ratio (95%CI) P-value Hazard ratio (95%CI) P-value
Age (o65/65–74/475 years) 1.71 (0.87–3.37) 0.12 — —
Gender (male/female) 1.11 (0.68–1.82) 0.69 — —
NCEPOD classification (elective/emergency/urgent/scheduled) 0.03 (1.29–7.09) 0.011 1.24 (0.69–2.24) 0.466
Physiology Score (11–14/15–20/21–30/430) 7.38 (2.70–20.19) 0.0005 8.64 (3.00–24.92) 0.0005
Dukes stage (Dukes A/B/C) 14.68 (4.56–47.26) 0.0005 15.02 (4.65–48.48) 0.0005
Tumour differentiation (well/moderate/poor) 3.65 (1.43–9.32) 0.007 1.52 (0.57–4.08) 0.40
Tumour site (colon/rectum) 0.85 (0.36–2.01) 0.71 — —
All adjuvant therapies (yes/no) 1.96 (1.17–3.27) 0.01 0.93 (0.50–1.74) 0.83
Smoking history (yes/no) 0.98 (0.60–1.61) 0.94 — —
Postoperative complications (yes/no) 1.61 (0.96–2.68) 0.07 —
CI¼confidence interval; NCEPOD¼National Confidential Enquiry into Perioperative Deaths. Bold values signify Po0.05.
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stherapy, those with poorer physiology were still significantly more
likely to have recurrent disease than those with better physiology.
Moreover, in multivariate analysis, the use of adjuvant/neo-
adjuvant therapy was not found to be an independent predictor
of survival, providing less emphasis to the caveat above.
We noted that postoperative complications were independently
associated with recurrence-free survival, but not cancer-specific
survival. All complications were considered together (anastomotic
leaks n¼8; respiratory tract infections n¼59 (13.7%); cardiac
complications n¼47 (10.9%); renal complications n¼20 (4.6%);
thromboembolic events n¼10 (2.3%); haemorrhage n¼4 (0.9%);
wound infection n¼48 (11.1%)). The impact of anastomotic leak
on immediate postoperative mortality and local recurrence is well
recognised (Bell et al, 2003; Walker et al, 2004). Recent reports
highlight importance in relation to long-term overall and cancer-
specific survival (McArdle and McMillan, 2005), although most
previous studies have had numbers of anastomotic leaks that are
too small to allow the detection of differences in survival. The
small numbers of clinical anastomotic leaks (n¼8) in this cohort
has precluded meaningful survival analysis. Other groups have
found postoperative infective complications to be independently
associated with cancer outcomes with inferior survival in those
sustaining complications (Nespoli et al, 2004). Poorer recurrence-
free survival may result from delays in the initiation of adjuvant
therapy or avoidance owing to prolonged patient recovery or ill
health. An alternative hypothesis is that postoperative complica-
tions may modify the systemic inflammatory response and provide
favourable conditions for tumour growth and hence recurrence.
In summary, disturbed patient physiology contributes to poorer
cancer-specific and recurrence-free survival of patients who have
undergone potentially curative surgery for CRC. This represents a
novel observation. Survival estimates may be enhanced by the
addition of clinical characteristics, for instance, patient physiology
to existing prognostic classifications.
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